T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Aptiv
APTV
$10.3B
| $558M | 0.12% |
8,906,881
+1,206,182
| +16% | +$84.3M |
|
202
RTX Corp
RTX
$302B
| $556M | 0.12% |
8,615,162
+2,245,012
| +35% | +$144M |
|
203
Tapestry
TPR
$32.4B
| $553M | 0.12% |
13,578,380
+6,078,108
| +81% | +$240M |
|
204
Keysight
KEYS
$58.7B
| $549M | 0.12% |
18,867,607
-2,171,109
| -10% | -$61.4M |
|
205
TE Connectivity
TEL
$63.3B
| $548M | 0.12% |
9,587,958
+1,858,400
| +24% | +$112M |
|
206
Global Payments
GPN
$22.7B
| $547M | 0.12% |
7,658,843
+306,030
| +4% | +$22.6M |
|
207
Acadia Healthcare
ACHC
$2.9B
| $546M | 0.12% |
9,854,528
+186,596
| +2% | +$10.9M |
|
208
Pediatrix Medical
MD
$2.12B
| $545M | 0.12% |
7,525,795
+46,575
| +0.6% | +$3.2M |
|
209
Coca-Cola
KO
$372B
| $544M | 0.12% |
11,992,106
-776,015
| -6% | -$35.1M |
|
|
WP
210
DELISTED
Worldpay, Inc.
WP
| $541M | 0.11% |
9,554,807
+48,611
| +0.5% | +$2.63M |
|
|
FEIC
211
DELISTED
FEI COMPANY
FEIC
| $524M | 0.11% |
4,903,758
-1,135,705
| -19% | -$109M |
|
212
Fidelity National Information Services
FIS
$22.1B
| $523M | 0.11% |
7,103,407
-151,438
| -2% | -$10.6M |
|
213
Union Pacific
UNP
$174B
| $522M | 0.11% |
5,979,905
-319,215
| -5% | -$27M |
|
214
American International
AIG
$40.4B
| $519M | 0.11% |
9,810,519
+5,723,452
| +140% | +$316M |
|
215
United Parcel Service
UPS
$88.8B
| $518M | 0.11% |
4,813,299
-118,035
| -2% | -$12.3M |
|
216
CME Group
CME
$93.2B
| $512M | 0.11% |
5,257,612
+482,330
| +10% | +$45.6M |
|
217
Carnival Corporation Ltd
CCL
$38B
| $511M | 0.11% |
11,570,012
-4,590,467
| -28% | -$225M |
|
218
Universal Health Services
UHS
$9.94B
| $503M | 0.11% |
3,754,185
-45,649
| -1% | -$6.02M |
|
219
Ametek
AME
$58.8B
| $502M | 0.11% |
10,856,803
-842,630
| -7% | -$40.5M |
|
|
COL
220
DELISTED
Rockwell Collins
COL
| $498M | 0.11% |
5,852,901
+1,710,461
| +41% | +$153M |
|
221
American Electric Power
AEP
$67.3B
| $498M | 0.11% |
7,108,065
+2,780,396
| +64% | +$182M |
|
222
BorgWarner
BWA
$14.2B
| $489M | 0.1% |
18,798,628
-3,888,304
| -17% | -$118M |
|
223
Public Storage
PSA
$60.7B
| $484M | 0.1% |
1,894,705
-94,114
| -5% | -$24.2M |
|
224
US Bancorp
USB
$100B
| $483M | 0.1% |
11,974,598
+3,365,056
| +39% | +$140M |
|
225
Prologis
PLD
$133B
| $479M | 0.1% |
9,758,681
+178,600
| +2% | +$8.39M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.